These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 17060971)
21. [Monoclonal antibodies. What obstacles to clear! What path to take!]. Lavelle F Bull Cancer; 2000 Nov; 87(11):776. PubMed ID: 11125286 [No Abstract] [Full Text] [Related]
22. Monoclonal Antibodies -- Visiongain's Second Annual Meeting. 29-30 June 2005, London, UK. Kneller S IDrugs; 2005 Sep; 8(9):713-5. PubMed ID: 16118689 [No Abstract] [Full Text] [Related]
23. For sale: custom cancer therapy. Med World News; 1985 Aug; 26(15):14, 16. PubMed ID: 10272464 [No Abstract] [Full Text] [Related]
24. Cancer therapy: a perspective and prospective view. Pack GT Indian J Cancer; 1965 Mar; 2(1):1-17. PubMed ID: 5318743 [No Abstract] [Full Text] [Related]
25. The cancer and metabolism link: researchers increasingly target metabolism in the search for new cancer treatments. Printz C Cancer; 2013 Aug; 119(15):2665-6. PubMed ID: 23868453 [No Abstract] [Full Text] [Related]
27. Differential Gene Expression in Erlotinib-Treated Fibroblasts. Wickersham KE; Hodges TK; Edelman MJ; Song Y; Nan M; Dorsey SG Nurs Res; 2019; 68(2):110-126. PubMed ID: 30540703 [TBL] [Abstract][Full Text] [Related]
28. Proliferation and migration of tumor cells in tapered channels. Wan Y; Tamuly D; Allen PB; Kim YT; Bachoo R; Ellington AD; Iqbal SM Biomed Microdevices; 2013 Aug; 15(4):635-643. PubMed ID: 23104156 [TBL] [Abstract][Full Text] [Related]
29. Defining the cancer master switch. Balentine CJ; Berger DH; Liu SH; Chen C; Nemunaitis J; Brunicardi FC World J Surg; 2011 Aug; 35(8):1738-45. PubMed ID: 21286716 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics of EGFR and VEGF inhibition. Pander J; Gelderblom H; Guchelaar HJ Drug Discov Today; 2007 Dec; 12(23-24):1054-60. PubMed ID: 18061885 [TBL] [Abstract][Full Text] [Related]
31. EGF receptors as a target for cancer therapy. Mendelsohn J Trans Am Clin Climatol Assoc; 2004; 115():249-53; discussion 253-4. PubMed ID: 17060971 [No Abstract] [Full Text] [Related]
32. Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapy. Huang SM; Li J; Harari PM Cancer Chemother Biol Response Modif; 2001; 19():339-52. PubMed ID: 11686022 [No Abstract] [Full Text] [Related]
33. [Targeting therapy directed against growth factor receptor]. Ueda M; Abe O; Shimizu N Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1436-42. PubMed ID: 1871365 [No Abstract] [Full Text] [Related]
34. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine. García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547 [TBL] [Abstract][Full Text] [Related]
35. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice. Baradaran B; Hosseini AZ; Majidi J; Farajnia S; Barar J; Saraf ZH; Abdolalizadeh J; Omidi Y Hum Antibodies; 2009; 18(1-2):11-6. PubMed ID: 19478394 [TBL] [Abstract][Full Text] [Related]